Heterochromic iridocyclitis
Fuchs’ syndrome is a chronic non-granulomatous iridocyclitis that mainly affects one eye. The disease is insidious in onset, with mild inflammation. It often presents with diffuse distribution behind the cornea or in the pupil area, star-shaped KP, iris depigmentation and other changes, and is prone to complications of cataracts and secondary glaucoma. This disease has many names in the literature (Table 1), many of which reflect the characteristics of heterochromia iris. However, in Chinese patients, due to the concentration of iris pigment, pigment loss is difficult to reach the level of causing heterochromia iris. Therefore, the names of Fuchs syndrome or Fuchs uveitis syndrome are more appropriate.
-
Site of disease:
Eye -
Infectious :
Not contagious -
Frequent population:
All groups -
Related symptoms:
Spontaneous intraocular hemorrhage visual impairment photophobia and tearing blindness due to pus accumulation in the eyeball blue iris -
Concurrent disease:
Related Drugs
Chymotrypsin for injection
Indication: It is a proteolytic enzyme that has the function of decomposing peptide chains. It can clean suppurative wounds, dissolve pus and necrotic tissue, promote the growth of granulation tissue, and selectively loosen the ciliary ligament. It can be used in combination with antibiotics and sulfonamides to treat various inflammations, ulcers, abscesses, hematomas, empyema, otitis media, and cataract removal.
Manufacturer:
Jilin Huinan Changlong BLO-CHEMICAL Pharmaceutcal Co., Ltd.
Prothiodine for injection
Indication: It is used for late-stage granulomatous or non-granulomatous iridocyclitis, retinal choroiditis, fundus hemorrhage, vitreous opacities, semi-old corneal leukoplakia, and leukoma. It can also be used as an adjuvant treatment for optic neuritis.